We are live on ! Find out more
ICCC icon

ImmuCell
ICCC

12 hedge funds and large institutions have $1.01M invested in ImmuCell in 2014 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

250% more repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 2

9% more funds holding

Funds holding: 11 → 12 (+1)

0.02% less ownership

Funds ownership: 7.61% → 7.59% (-0.02%)

9% less capital invested

Capital invested by funds: $1.1M → $1.01M (-$94K)

Holders
12
Holders Change
+1
Holders Change %
+9.09%
% of All Funds
0.34%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
7
Reduced
2
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
SKK
Shepherd Kaplan Krochuk
Massachusetts
+$16.8K
2
Wells Fargo
Wells Fargo
California
+$8.42K
3
Renaissance Technologies
Renaissance Technologies
New York
+$7.58K
4
SRC
Shufro Rose & Co
New York
+$4.65K
5
U
UBS
Switzerland
+$3.59K

Top Sellers

Rank Fund Capital Flow
1
Morgan Stanley
Morgan Stanley
New York
-$36.7K
2
HP
HealthInvest Partners
Sweden
-$10.4K

ICCC Hedge Fund Activity: Q2 2014 in Review

12 of the 3,491 institutional investors tracked by Wall St. Rank reported a position in ImmuCell (ICCC) for Q2 2014, worth a combined $1.01M — down 8.5% from $1.1M a quarter earlier.

Buyers outnumbered sellers: 1 fund opened new ICCC positions and 0 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.

The largest buyer was Shepherd Kaplan Krochuk, adding an estimated $16.8K. The largest seller was Morgan Stanley, cutting an estimated $36.7K.

  • 12 institutional investors held ImmuCell (ICCC) as of Q2 2014, up from 11 in Q1 2014.
  • Funds reported $1.01M of ImmuCell stock for Q2 2014, down 8.5% quarter-over-quarter.
  • 1 fund opened new ImmuCell positions in Q2 2014 and 0 closed out, a net change of +1 holder.
  • The largest ImmuCell buyer in Q2 2014 was Shepherd Kaplan Krochuk, an estimated $16.8K added.
  • The largest ImmuCell seller in Q2 2014 was Morgan Stanley, an estimated $36.7K sold.

Based on aggregated 13F filings for Q2 2014.